Correction
After the publication of this work [1] it was brought to the authors’ attention that Figures six (Figure 1 here) (E) and (F) contained an error in their data presentation. The correct figure is given below.
The tumor-suppressive and chemosensitivity functions of miR-34a were mediated by reduction the production of CD44. Downregulation of CD44 by siRNA led to similar effect of miR-34a overexpression on A) cell proliferation (mean ± SEM; n = 3; *p < 0.05) and B-C) tumorigenity (mean + SEM; n = 3; *p < 0.05). Increased CD44 expression could efficiently reverse the effect of miR-34a on MIBC D) cell proliferation (mean ± SEM; n = 3; *p < 0.05), E-F) colongenic potential and G) chemosensitivity (mean + SEM; n = 3; *p < 0.05).
We regret any inconvenience that this inaccuracy may have caused.
References
Heng L, Gan Y, Runlin S, Bin L, Xianguo C, Ding X, Haibing X, Xiaolin G, Wei G, Zhangqun Y, Wei X, Hua X: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy. Molecular Cancer. 2014, 13: 8- 10.1186/1476-4598-13-8
Author information
Authors and Affiliations
Corresponding authors
Additional information
The online version of the original article can be found at 10.1186/1476-4598-13-8
Heng Li, Gan Yu contributed equally to this work.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Li, H., Yu, G., Shi, R. et al. Erratum To: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy. Mol Cancer 13, 183 (2014). https://doi.org/10.1186/1476-4598-13-183
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/1476-4598-13-183